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Background: Polyunsaturated fatty acids (PUFAs) have positive effect on the regulation of plasma lipids. But the
mechanism for them to modulate lipid homeostasis in macrophage is still unclear. In this study, we employed
PUFA to pretreat macrophages and evaluated the variations of lipid droplet (LD) content, lipid composition, and
expressions of LD-associated genes in macrophage-derived foam cells.
Method: THP-1-derived macrophages or human peripheral blood monocyte-derived macrophages were pre-treated
with four non-esterified fatty acids (NEFAs) separately: saturated fatty acid (SFA)-palmitic acid (PA), monounsaturated
fatty acids (MUFAs)-oleic acid (OA), PUFAs-linoleic acid (LA) and eicosapentaenoic acid (EPA). Intracellular lipid content
and cholesterol efflux were analyzed in THP-1 macrophage-derived foam cells. Related gene expressions were detected
by quantitative real-time PCR.
Results: PUFA pre-treatment reduced cholesterol content in foam cells and increased cholesterol efflux to lipid-free
apoAI in conditioned medium compared with PA or OA group. Cell death-inducing DFF45 like effector (CIDE) and
Perilipin-Adipophilin-TIP47 (PAT) family members, as LD-associated proteins, showed specific gene expression profiles
after PUFA pre-treatment. These results may help to explain the process of lipid metabolism within foam cells.
Conclusion: PUFA (LA or EPA) had a potential protective effect against cholesterol accumulation. The specific
expressions of CIDE and PAT genes may provide clues to explore the protective mechanism of PUFA in foam cells.
Keywords: Polyunsaturated fatty acid, CIDE, PAT, Lipid metabolism, AtherosclerosisBackground
PUFAs are essential components in lipid metabolism. It
has been reported that PUFAs can affect lipid storage
and reduce the risk factors of cardiovascular diseases [1].
However, the potential role of PUFA in the formation of
fatty streak and atherosclerotic plaque is not yet clear.
The molecular mechanism for PUFA-induced lipid
influx and efflux in foam cells is inconclusive.
Abnormal lipid deposition in the intima of artery wall
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reproduction in any medium, provided the orup the oxidized LDL (ox-LDL), stores a large portion of
lipids in their cytoplasm, and turn into foam cells [2,3].
The formation, morphology and lipolysis of intracellular
LDs are regulated by a number of LD-associated pro-
teins [4]. These proteins are located on the surface of
LDs and play active roles in the regulation of intracellu-
lar lipid storage, nascent LD biogenesis and transporta-
tion [5-8]. CIDE and PAT proteins are by far the most
specific LD-associated proteins being found. Proteomic
analyses also confirmed that the most abundant proteins
in LDs were the CIDE and PAT family members [9]. The
peroxisome proliferator-activated receptor γ (PPARγ) is
considered as an important transcription factor involved
in the regulation of gene expression of most of LD-
associated proteins [10-12]. Microarray analysis in ourtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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together with PPARγ regulated proteins, had meaningful
expression changes in the process of THP-1 macrophage-
derived foam cells formation. These data suggested that
CIDE or PAT proteins were closely related to intracellular
LD formation. But different NEFA-induced protein ex-
pressions are still not clear.
In this study, THP-1-derived macrophages and peri-
pheral blood monocyte-derived macrophages were pre-
treated separately with PA, OA, LA and EPA (difference
in saturation). We intend to simulate a microenvironment
of monocyte-derived macrophages in artery wall. The lipid
composition of intracellular LDs was identified by quanti-
tative analysis in two cell groups separately. By analyzing
cholesterol efflux and mRNA expression profiles of CIDE,
PAT and PPARγ transcriptional regulatory proteins in
THP-1 macrophage-derived foam cells, we try to present a
potential relationship among PUFA pre-treatment, lipid
loading and LD-associated gene expression.
Results
Identification of the optimum incubation condition
Before the experiment, we examined the cytotoxicity of
employed fatty acids on THP-1 macrophages with MTT
assay. NEFA pre-treatment increased cell death rate in a
time- and dose-dependent manner (Figure 1). Compared
with the control group, 48 hours’ incubation by each
NEFA had no effect on macrophage viability. While after
72 hours’ incubation, there were at least 75% cells sur-
vived in each group, which is sufficient for the following
experiments. Concentration of NEFAs can also affect
macrophage viability. Cell survival rate decreased slightlyFigure 1 Cell viability of THP-1 macrophage after pre-treatment
with different NEFAs at different concentrations for 72 hours.
The THP-1-derived macrophages were pretreated by PA, OA, LA and
EPA separately with time and dose gradients. The cell viability was
determined by MTT colorimetric assay. Data represent mean ±
SEM (n = 3).after 72 hours pre-treatment with 100 μM NEFAs. How-
ever, when the concentration was elevated to 200 μM,
all the NEFAs markedly decreased cell viability (P < 0.05
separately). Therefore, we chose 100 μM and 72 hours
as the optimum concentration and time condition for
macrophages incubation in the following study.
PUFA induced relatively lower lipid content in foam cells
THP-1-derived macrophages were separately exposed to
different NEFAs in advance for 72 hours. Then ox-LDL
was added to facilitate the formation of foam cells. Intra-
cellular LDs were stained with Nile Red (Figure 2A). And
the LD content was quantified by measuring the positive
area in macrophages and foam cells (Figure 2B). Due to
the intake of ox-LDL, foam cells in the control group
contained more LDs compared with non-ox-LDL treated
THP-1 macrophages. All the four NEFAs could efficiently
increase the total area of LDs in foam cells compared with
control (P < 0.05). Lipid content in PUFA group was lower
than that in PA and OA group (P < 0.05). To verify the
effect of pre-treatment of PUFA, we then incubated
human peripheral blood monocyte-derived macrophages
with different NEFAs separately. The quantitative analysis
of lipid content in foam cells was consistent with that in
THP-1 macrophage-derived foam cells (Figure 2A-B).
These findings illustrated that, compared with PA and
OA, PUFAs (LA and EPA) could cause relatively less lipid
content during foam cells formation.PUFA relatively inhibited cholesterol accumulation in
foam cells
We measured intracellular TG, TC and CE levels in both
THP-1 macrophage- and monocyte macrophage-derived
foam cells. Each NEFA could elevate the level of TG com-
pared with respective control (P < 0.05, Figure 3A). PUFA
induced less accumulation of TC and CE than PA or OA
did during the process of foam cell formation (P < 0.05
respectively, Figure 3B-C). These results indicated that the
lower lipid content in PUFA pre-treated group was partly
due to less cholesterol accumulation.
PUFA increased cholesterol efflux to lipid-free apoAI in
conditioned medium
To test whether the lower intracellular cholesterol
accumulation was caused, at least partly, by increased
cholesterol efflux, we performed cholesterol efflux as-
says. We detected the amount of cholesterol efflux from
THP-1 macrophage-derived foam cells to either lipid-
free apoAI or to HDL in medium. There was no statis-
tical significance in cholesterol efflux to HDL among
NEFA groups. But cholesterol efflux to lipid-free apoAI
was markedly increased in PUFAs (LA and EPA) groups
compared with that in PA or OA group (Figure 4).
Figure 2 (See legend on next page.)
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Figure 2 Effects of PUFAs on intracellular lipid accumulation. Both THP-1 macrophages and monocyte macrophage were pre-treated with
different NEFA at the concentration of 100 μM for 72 hours. Then ox-LDL was added to facilitate foam cell formation. The intracellular lipid
droplets were stained with Nile Red (A). The average positive area of stained LDs per cell was used to quantify the intracellular lipid content
(B). Data represent mean ± SEM (n = 3). ※P < 0.05 vs. control; #P < 0.05 vs. PA/OA group.
Figure 3 Quantitative determination of TG, TC and CE in foam cells. The THP-1 macrophages or monocyte macrophages were pre-treated
with different NEFA in advance, and then ox-LDL was added to facilitate foam cell formation. Intracellular TG, TC and free cholesterol were
determined by enzymatic colorimetric assays (A-B). The concentration of CE was determined by subtracting free cholesterol from TC (C).
Data represent mean ± SEM (n = 3).※/#P < 0.05 vs. control (A); †/‡P < 0.05 vs. PA/OA group (B-C).
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Figure 4 Effects of PUFAs on cholesterol efflux to lipid-free
apoAI or to HDL. THP-1 macrophages or monocyte-macrophages
were pre-treated with different NEFA, and then incubated with ox-LDL
containing 1 μCi/ml [3H] cholesterol and 2 mg/ml BSA. The
radioactivity was measured by scintillation counting. Cholesterol efflux
to apoAI from foam cells was increased in LA and EPA groups. PUFAs
had no effect on cholesterol efflux to HDL from foam cells. Data
represent mean ± SEM (n = 3). ※P < 0.05 vs. control.
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proteins were closely correlated with intracellular lipid
content
PPARγ is a critical nuclear receptor regulating the
expression of LD-associated proteins [6], part of which
have been found having specific expression profiles
during foam cell formation [8,12]. In our previous
microarray analysis, we found that the expression of SR-
A1, CD36, ABCA1 and apoAI showed interesting changes.
In this study, we tried to clarify potential roles of these
genes in modulating cellular lipid loading after PUFA
pre-treatment. Data in Figure 5 and Table 1 directly
showed fold-changes of related mRNAs in foam cells vs. in
macrophages. Specific NEFA induced mRNA expressionFigure 5 Effects of PUFAs on the mRNA expressions of PPARγ transcr
foam cell formation. The THP-1 macrophages were pre-treated with differen
formation. Total RNAs were extracted from both macrophages and foam cells a
were measured by real-time PCR. Data represent mean ± SEM (n = 3). ※P< 0.05on macrophages and foam cells were shown in Additional
file 1: Figure S1 and Additional file 2: Figure S2.
PPARγ can be activated by some long-chain saturated
or unsaturated fatty acids. We found that PUFA sepa-
rately decreased the expression of SR-A1 and CD36,
while increased the expression of apoAI in foam cells
compared with PA or OA. PUFA also induced notable
fold-increase of apoAI compared with the untreated
foam cell control. ABCA1 was markedly up-regulated by
EPA but not by LA. The expression profiles of PPARγ
related proteins induced by PUFAs were, to a great
extent, consistent with lower cholesterol accumulation
and higher cholesterol efflux. SFA and MUFA neither
showed protective effect against lipid loading nor indu-
ced similar expressions of related genes as PUFAs in
foam cells.
Expression profiles of CIDE and PAT members were
correlated with PUFAs induced LD formation
Our previous study has shown that LD-associated pro-
teins have specific expression profiles in the process of
foam cell formation. In this study, we further investigate
NEFA-induced alterations of CIDE and PAT members in
foam cells.
As shown in Figure 6A and Table 1, PUFA significantly
up-regulated the expression of Cidea and Cidec while
reduced the expression of Cideb compared with the foam
cell control. PAT family members have been proved to be
the dominant LD-associated proteins. NEFA-induced fold-
changes of PAT members in transcriptional level were
showed in Figure 6B and Table 1. ADRP, a protein which
has similar function with Perilipin, increased remarkablyiptional regulated proteins during THP-1 macrophage-derived
t NEFA in advance, and then ox-LDL was added to facilitate foam cell
nd reverse-transcribed into cDNA. PPARγ, SR-A1, CD36, ABCA1 and apoAI
vs. the value in macrophages; †P< 0.05 vs. the un-treated control.
Figure 6 Effects of PUFAs on the mRNA expressions of CIDE and PAT
macrophages were pre-treated with different NEFA in advance, and then o
extracted from both macrophages and foam cells and reverse-transcribed i
real-time PCR. Data represent mean ± SEM (n = 3). ※P < 0.05 vs. the value in
Table 1 Specific NEFA induced fold-changes of mRNAs
Protein Control PA OA LA EPA
SR-A1 −0.25 −0.61* 1.12* −1.30*# −0.96*#
CD36 0.81 0.32 0.26 −1.03* −0.67*
ABCA1 2.15 −0.36 −0.26 0.11 1.20*
ApoAI 1.15 2.82* −4.73* 3.02*# 5.24*#
PPARγ 0.18 1.30*# 0.17 0.18 0.48*
Cidea 0.02 −1.54* −3.87* 3.17*# 1.02#
Cideb 1.35 2.43* 1.67* 0.28# 0.17#
Cidec 0.65 −0.24 −0.27 0.84# 1.75*#
Perilipin −0.15 −2.11* −3.04* 2.42* −0.24
ADRP 4.05 5.22* 4.36* 9.55*# 7.78*#
TIP47 0.99 1.39* 0.54* −1.79* 2.04*#
S3-12 0.38 2.10* −2.80* 6.30*# 3.21*#
LSDP5 1.03 1.60* −2.02* 2.96*# 0.10
Values were presented as: log2 (mRNA level in foam cell/mRNA level
in macrophage).
(*P < 0.05; #P < 0.05 vs. respective control).
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increase in PUFA groups compared with it in PA or OA
group. Interestingly, of all employed NEFAs, LA induced
the highest fold-increase of PAT members except for
TIP47, and EPA similarly induced significantly fold-
increase of PAT members except for Perilipin. These
specific gene expression profiles, combined with their
functions in the process of LD formation, provided a
relevant explanation to the alterations of intracellular lipid
content.
Discussion
Numerous studies show that PUFAs play potential roles in
maintaining serum lipid homeostasis. Population-based
study found that high level of fish intake was good for
cardiovascular health [13]. PUFA had been reported to be
a protective agent against atherosclerosis (AS) [14,15]. In
this study, we chose different NEFAs according to their
importance in human diet. NEFAs are rich in meat (PA),
plant fats (OA, LA), and fish oils (EPA n-3). PA (16:0), OA
(18:1 n-9), and LA(18:2 n-6) are the most abundant fatty
acids in fatty streaks of human [16]. Our study confirmed
that compared with SFA and MUFA, PUFAs (LA andmembers during NEFA-induced LD formation. The THP-1
x-LDL was added to facilitate foam cells formation. Total RNAs were
nto cDNA. CIDE (A) and PAT (B) family members were measured by
macrophages; †P < 0.05 vs. the un-treated control.
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lower the total lipid content in foam cells. However,
NEFAs were stored as TGs in budding LDs and ox-LDL
lipids were added to the pre-existing ones, which
increased sizes of LDs finally. This helps to explain the
theory that PUFA promotes the storage of TG.
NEFAs regulate gene expressions by acting directly or
indirectly as ligands for nuclear acceptors [17]. PPARγ
binds DNA in the form of heterodimer with retinoid X
receptor (RXR) and maintains lipid homeostasis in macro-
phages by regulating the expression of scavenger receptors
including SR-A1 and CD36 [5]. Meanwhile, PPARγ is the
upstream regulator of ATP-binding cassette transporter
ABCA1 and apolipoprotein AI (apoAI). The classic path-
way of cholesterol efflux from macrophages is that CD36 or
SR-A1 on the surface of macrophages recognizes and
engulfs ox-LDL, and then ABCA1 exports cholesterol and
phospholipids to lipid-free apoAI, forming small HDL
particles [6]. In this study, EPA or LA significantly reduced
the gene expression of SR-A1 and CD36, and EPA further
increased the expression of ABCA1. These alterations
corporately contributed to the less cholesterol uptake and
more cholesterol efflux. Though lipid-poor apoAI is not
synthesized by macrophages, we found PUFAs could up-
regulate the mRNA level of apoAI. It is worth noting that
the higher expression of apoAI increased cholesterol efflux
in macrophages [18]. The protective effects of apoAI can
also be attributed to its anti-inflammatory and antioxidative
properties, not directly related to plasma HDL cholesterol
levels [19]. NEFA-induced lipid accumulation in foam cells
may be caused by increased lipid influx mediated by CD36.
The up-regulation of ABCA1 was accompanied by the
increased cholesterol efflux to apoAI and the reduced
intracellular lipid content. These findings suggested that
ABCA1 played a key role in regulating intracellular lipid
accumulation. The ABCA1 appears to be the most effect-
ive receptor in mediating cholesterol efflux to apoAI. The
half transporter ABCG1 also, to some extent, facilitates
cholesterol efflux to HDL as acceptor [20-22]. The ele-
vated cholesterol efflux to apoAI in medium rather than
to HDL in EPA group supported the finding that EPA may
induce more cholesterol efflux through ABCA1 pathway.
But the lower fold-increase of ABCA1 in LA group
indicated that there might be other pathways participating
in the modulation of cholesterol efflux. But the changes of
ABCA1 and ABCG1 in protein level have not been inves-
tigated in our experiment. Further study in this area is
needed.
CIDE family consists of Cidea, Cideb and Cidec/Cide3.
They play important roles in lipid storage, LD formation
and lipolysis [23]. But their expression profiles and func-
tions in AS is still unclear. Cidea protein, surrounding LDs
and co-localizing with Perilipin, can efficiently repress
lipolysis in human adipocytes [24,25]. Cidec inhibitslipolysis, promotes TG accumulation and contributes to
the stability of formed LDs [8,13,24]. Fold-increase of Cidea
and Cidec in PUFAs pre-treated foam cells may be helpful
to promote TG accumulation and inhibit lipolysis [3,26].
Thus PUFA may exert its protective role by reducing the
lipotoxicity in foam cells. Our previous study showed that
the down-regulation of Cideb was closely related to the
enhanced hepatic fatty acid oxidation [27]. It is certain
that Cideb plays an important role in affecting lipid
metabolism in foam cells, though whether Cideb could
enhance lipid oxidation or lipolysis still needs further
investigation.
PAT family is composed of five members: Perilipin,
ADRP, TIP47, S3-12 and LSDP5. Perilipin and ADRP are
constitutive proteins on LD membranes [28,29]. ADRP
participates in LD formation in macrophages and foam
cells [30] and facilitates cholesterol efflux from macro-
phages [31]. The increased ADRP and Perilipin in PUFA
pre-treated group may help to reduce the toxicity of NEFA
and contributes to the synthesis of lipid (including TG).
Nascent LDs are predominantly decorated by TIP47 and
S3-12 [17]. As lipid droplet coats, these two proteins are
interchangeable and are necessary for TG storage [5,30].
LSDP5 is a PPARγ-induced LD-associated protein which
can promote the fatty acid positioning. The expression of
LSDP5 is also associated with the increased TG accumu-
lation, for it can promote expansion of the storage pool
of lipid substrates [28,32]. In conclusion, PUFAs have
positive effect on maintaining TG content, reducing TC
and CE contents in LDs. These effects may be closely
related to the separate or combined expression of CIDE
and PAT members. The meaningful alterations of these
LD-associated proteins in mRNA level may provide us
new ideas to explore lipid metabolism in foam cells.
Although PUFAs could not completely resist lipid
deposition in foam cells, it can effectively reduce the
accumulation of cholesterol. Several factors related to
lipid metabolism in foam cells have been observed in
this study, but the cause-effect studies have not been
thoroughly conducted and further investigation is
needed.
This study addressed that PUFAs pre-treated macro-
phage-derived foam cells showed dynamic gene changes.
The expression of PPARγ and LD-associated proteins
in transcriptional level can be, at least in part, linked to
the process of LD formation. In summary, the different
effects of NEFAs on TG and cholesterol flux in foam
cells depend on an integrated function of relevant
genes. We believe that the gene expression profiles of
CIDE and PAT members should also be used as
important indicators of LD metabolism in foam cells.
More detailed researches should be performed in
future to clarify the mechanism of lipid accumulation
in foam cells.
Table 2 Real-time PCR primer sequences
Gene Primer sequences Genebank
number
SR-A1 Forward: CCAGGGACATGGGAATGCAA NM_138715.2
Reverse: CCAGTGGGACCTCGATCTCC
CD36 Forward: GAGAACTGTTATGGGGCTAT NM_001001548.2
Reverse: TTCAACTGGAGAGGCAAAGG
ABCA1 Forward: GCACTGAGGAAGATGCTGAAA NM_005502.2
Reverse: AGTTCCTGGAAGGTCTT GTTC
ApoAI Forward: TGTGTCCCAGTTTGAAGGC NM_000039.1
Reverse: CTCCTTTTCCAGGTTATCCCAG
PPARγ Forward: CACAAGAACAGATCCAGTGGTTGCAG NM_005037.5
Reverse: AATAATAAGGTGGAGATGCAGGCTCC
Cidea Forward: GGGATCACAGACTAAGCGAG NM_001279.3
Reverse: TGACGAGGGCATCCAGAG
Cideb Forward: TGATGGTGTTGCAGTCTGG NM_014430.2
Reverse: AAAGAGGTCTCGAGGGTTTTG
Cidec Forward: TTGATGTGGCCCGTGTAACGTTTG NM_022094.2
Reverse: AAGCTTCCTTCATGATGCGCTTGG
Perilipin Forward: GCCATGTCCCTATCAGATGC NM_001145311.1
Reverse: GTTGTCGATGTCCCGGAATT
ADRP Forward: CTGAGCACATCGAGTCACATACTCT NM_001122.2
Reverse: GGAGCGTCTGGCATGTAGTGT
TIP47 Forward: GCTGGACAAGTTGGAGGAGA NM_001164189.1
Reverse: CCGACACCTTAGACGACACA
S3-12 Forward: ACATCTTCCACCCCATGAATG NM_001080400.1
Reverse: GTGTTCAAATGCCCGCTG
LSDP5 Forward: AGCACGATGTCTGAAGAAGAG DQ_839131.1
Reverse: TCCTTGGCTGCACTGTAAAC
HPRT1 Forward: TGACACTGGCAAAACAATGCA NM_005502.2
Reverse: GGTCCTTTTCACCAGCAAGCT
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Materials
Human monocytic leukemia THP-1 cells were kindly do-
nated by Dr. Bo-quan Jin (Department of Immunology,
Fourth Military Medical University, Shaanxi, China).
Human buffy coats were purchased from blood bank of
Xijing Hospital (Fourth Military Medical University,
Shaanxi, China). Whole human HDL (density = 1.063-
1.021, containing HDL2 and HDL3) was purchased from
Union Medical College (Beijing, China). Unless other-
wise specified, all other reagents were purchased from
Sigma-Aldrich (Shanghai, China).
Monocyte isolation
A two-step procedure was used to isolate monocyte
from buffy coats. Firstly, peripheral blood mononuclear
cells (PBMCs) were isolated from buffy coats using a
Ficoll-Hypaque gradient (density = 1.070). Then a slight
hyperosmolar Percoll gradient (density = 1.064) was
used for monocyte isolation [33]. Percoll solutions were
prepared as follows: first an isosmotic Percoll was
prepared by mixing one volume NaCl 1.5 M with nine
volumes of Percoll (density = 1.130). Then the Percoll
gradient was done by mixing isosmotic Percoll with
PBS/Citrate (NaH2PO4 1.49 mM; Na2HPO4 9.15 mM;
NaCl 139.97 mM; C6H5Na3O7.2H2O 13 mM; pH 7.2) in
a 1: 1 (v/ v) ratio. Both gradients were centrifuged at 25-
35°C, 400 g for 35 min. The purity of monocytes after
the Percoll gradient isolation was higher than 85%.
Platelets were eliminated by low speed centrifugation
(100 g) after the Percoll gradient isolation.
Cell culture
THP-1 cells and human peripheral monocytes were
cultured in RPMI-1640 medium (Gibco, US) supplemented
with 10% fetal bovine serum (FBS, Gibco, US), penicillin
(100 U/ml) and streptomycin (100 μg/ml) in CO2/O2 incu-
bator at 37°C. Then cells were incubated with 100 ng/ml
phorbol 12-myristate 13-acetate (PMA) for 24 hours to
facilitate macrophage formation. The adherent macro-
phages were washed three times with phosphate-buffered
saline (PBS) and incubated with cell culture medium
containing 2% FBS for another 24 hours with or without
NEFA. After the incubation, macrophages were treated
with 50 μg/ml ox-LDL for another 48 hours for foam cell
formation.
Toxicology assay
The THP-1-derived macrophages were treated by differ-
ent NEFAs separately with time and dose gradients. The
cell viability was tested using 3-(4,5-Dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT) colorimetric
assay as previously described [34]. THP-1 macro-
phages were separately cultured with NEFAs in a finalconcentration from 50 μM to 200 μM in 96-well micro
plates for 24 hours to 96 hours. After an appropriate
incubation (37°C, 4 hours with 20 μl MTT (5 mg/ml) in
each well), 150 μl dimethyl sulfoxide (DMSO) was used to
replace the medium containing MTT, and then plates
were shook for 10 minutes. Absorbance at 490 nm was
measured. Each experiment was independently repeated
three times. Bovine serum albumin (BSA) mixed with
DMSO and PBS was set as the control.
Isolation and oxidation of LDL
Native LDL (density = 1.020-1.063) were isolated from
human plasma by sequential flotation ultracentrifugation
at 60,000 rpm (24 hours, 10°C). Before oxidative modifica-
tion, the LDL was dialyzed against PBS, filtered through a
0.2 μm millipore membrane and stored in PBS containing
10 mM EDTA at 4°C. LDL oxidation was induced by
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ratios of 2000/1) for 30 min at 37°C. Ox-LDL was dialyzed
overnight against saline (0.15 M NaCl and 300 μM EDTA,
pH 7.4). The protein concentration was determined by
methods of Lowry [35].
NEFA pre-treatment
Macrophages were exposed to NEFAs at a final concentra-
tion of 100 μM which was within the physiologic plasma
range [32,36]. After 24 hours incubation, 50 μg/ml ox-LDL
was added. Macrophages were incubated for another
48 hours to induce foam cells formation. Each NEFA
was conjugated by fatty acid free BSA in a 4:1 molar ratio
at 37°C for at least 1 hour prior to treatment as previously
described [37]. NEFA was added to the culture medium
with a minimal volume (< 0.1%) of DMSO. Three inde-
pendent experiments with triplicate samples (each sam-
ple with 2.5 × 106 cells/60 mm dish) were performed for
each test.
Cholesterol loading and efflux
After treatment with PMA and NEFA, THP-1 macrophage
were washed with PBS and incubated with 50 μg/ml
ox-LDL, 1 μCi/ml [3H] cholesterol and 2 mg/ml BSA for
40 hours. After 8 h equilibration with MEM containing
1 mg/ml of BSA, macrophages were washed twice with
PBS and treated for 12 h with serum-free medium
containing: (1).2 mg/ml BSA; (2).2 mg/ml BSA and
15 μg/ml lipid-free human apoAI; (3).2 mg/ml BSA and
50 μg/ml of human HDL. Then the supernatant was
collected and centrifuged at 12 000 rpm for 15 min to
remove debris. Cells were lysed with 0.5 ml of 0.1 N
NaOH. The radioactivity in both the supernatant and
cellular lipid was measured by scintillation counting.
Background efflux was determined by control cells
incubated with 2 mg/ml BSA. Human HDL was pre-
pared as previously described [38,39]. The data were
normalized by total [3H]-cholesterol radioactivity in
supernatant and cell pellet.
Real time quantitative PCR assay
The targeted genes, primer sequences and Genebank
number for real-time PCR assays performed in this study
are summarized in Table 2. Total RNA was extracted from
macrophages and foam cells (THP-1 cell line) with Trizol
reagent (Invitrogen, US) and then reverse transcribed to
cDNA in a final volume of 30 μl. Real-time PCR assays
were performed with an iCycler IQ Real Time PCR
Detection System (BIO-RAD,US) and the SYBR Prime
Script RT-PCR Kit (Takara Dalian, China). 5 pmol
primer and 100 ng cDNA were used in a final volume of
25 μl. Homo sapiens hypoxanthine phosphoribosyl trans-
ferase 1 (HPRT1) was used as a housekeeping gene for its
stable expression in monocytes and macrophages. ThePCR amplification program was 95°C for 3 minutes,
followed by 45 cycles of 95°C for 30 seconds (s), 60°C
for 30 s and 72°C for 30 s. All samples were tested
three times.
Lipid analysis
Cells were fixed in 4% paraformaldehyde for 30 minutes,
and then washed three times with PBS before incubated
in a working solution of Nile Red. Nucleus of the cell
was dyed with Hoechst 33258 as previously described
[8]. The image of lipid staining was captured and quanti-
fied by Olympus Type BX51TRF microscope (Olympus
Co., Japan) and Image-Pro Plus 6.0 software (Media
Cybernetics, US). Cell lipids were extracted with hexane:
isopropanol at 3:2 (vol: vol). The quantities of cellular
TG, TC and free cholesterol were determined by enzy-
matic colorimetric assays using commercial reagents
(Wako Pure Chemical Industries, Japan) according to
the manufacturer’s protocol. The concentration of CE
was determined by subtracting free cholesterol from TC.
After lipid extraction, residual proteins were used for
protein quantitative determination.
Data presentation
A transformed ratio was used to calculate fold-change of
mRNA in the process of macrophages differentiation
into foam cells. The fold-change of mRNA in foam cells
vs. in macrophages was calculated as: log2(mRNA level in
foam cell/mRNA level in macrophage). We specified the
value of log2(mRNA level in foam cell control/mRNA level
in macrophage control) as the control for all the samples
in a particular study. The baseline was set to be Ratio
(logarithm scale) = 0, which means that bars with ratios
greater than one (increase) pointed up, and ratios smaller
than one (decrease) pointed down.
Statistics
Results were expressed as mean ± SEM. Differences be-
tween groups were determined using one way analysis of
variance (ANOVA). Dunnett’s-t test was used for a mul-
tiple comparison. P < 0.05 was taken as significance.Additional files
Additional file 1: Figure S1. Specific mRNA expressions of proteins
with transcription regulated by PPARγ in NEFA pre-treated macrophages
and foam cells. Data represent mean ± SEM (n = 3). ※P < 0.05 vs. the
value in macrophages; †P < 0.05 vs. the macrophage control; ‡P < 0.05 vs.
the foam cell control.
Additional file 2: Figure S2. Specific mRNA expressions of LD-associated
proteins in NEFA pre-treated macrophages and foam cells
(A.CIDE family members; B. PAT family members). Data represent mean ±
SEM (n = 3). ※P < 0.05 vs. the value in macrophages; †P < 0.05 vs. the
macrophage control; ‡P < 0.05 vs. the foam cell control.
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